Figure 2From: Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitroTAM combined with tranilast additively inhibits survival of MCF-7 (A) and MDA-MB-231 (B) cells at 48 h. Shown are the mean values of three experiments ± SE. p values were determined using one-way ANOVA (*p < 0.05, **p < 0.01, ***p < 0.001 compared with control).Back to article page